A new Prenylated Flavonoid induces G0/G1 arrest and apoptosis through p38/JNK MAPK pathways in Human Hepatocellular Carcinoma cells

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Wang, Di ^a   Sun, Qian ^a   Wu, Jie ^a   Wang, Wei ^a   Yao, Guodong ^a   Li, Tianyang ^a   Li, Xue ^a   Li, Lingzhi ^a   Zhang, Yan ^a   Cui, Wei ^a   Song, Shaojiang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; FLAVONOID; PHYTOCHEMICAL;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CANCER TRANSPLANTATION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMISTRY; DAPHNE; DISEASE MODEL; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; LIVER CELL CARCINOMA; MAPK SIGNALING; NUDE MOUSE; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DAPHNE; DISEASE MODELS, ANIMAL; FLAVONOIDS; HETEROGRAFTS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHYTOCHEMICALS; TREATMENT OUTCOME;

EID: 85025147487     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05955-0     Document Type: Article

References (52)

1. Cheng, J. S. et al. The effect of oleuropein from olive leaf (Olea europaea) extract on Ca(2+) homeostasis, cytotoxicity, cell cycle distribution and ROS signaling in HepG2 human hepatoma cells. Food Chem Toxicol 91, 151-166 (2016).
2. Hoda, M., Pajaniradje, S., Shakya, G., Mohankumar, K. & Rajagopalan, R. Anti-proliferative and apoptosis-Triggering potential of disulfiram and disulfiram-loaded polysorbate 80-stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line. Nanomedicine. 12, 1641-1650 (2016).
3. Pang, R. W. et al. Biology of hepatocellular carcinoma. Ann surg Oncol 15, 962-971 (2008).
4. Wu, S. H. et al. Anti-cancerous effects of Wasabia japonica extract in Hep3B liver cancer cells via ROS accumulation, DNA damage and p73-mediated apoptosis. J Funct Foods 14, 445-455 (2015).
5. Mauer, K., O'Kelley, R., Podda, N., Flanagan, S. & Gadani, S. New treatment modalities for hepatocellular cancer. Curr Gastroenterol Rep 17, 442 (2015).
6. Wang, Y., Deng, T., Zeng, L. & Chen, W. Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta-Analysis. Hepatology. 46, 58-71 (2016).
7. Liu, G. et al. Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells. Cancer Lett. 383, 171-182 (2016).
8. Bruix, J. et al. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): A phase 3, randomised, double-blind, placebo-controlled trial. Lancet. Oncol. 16, 1344-1354 (2015).
9. Horgan, A. M., Dawson, L. A., Swaminath, A. & Knox, J. J. Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma. J Gastrointest Cancer 43, 344-348 (2012).
10. Tabernero, J. et al. Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: The RESPECT trial. Clin Cancer Res 19, 2541-2550 (2013).
11. Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: A changing paradigm. Nature reviews. Cancer. 9, 153-166 (2009).
12. Yu, S. Y. et al. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer. J. Agric. Food Chem. 62, 2085-2095 (2014).
13. Bloom, J. & Cross, F. R. Multiple levels of cyclin specificity in cell-cycle control. Nature reviews. J Mol Cell Biol 8, 149-160 (2007).
14. Malumbres, M. & Barbacid, M. Mammalian cyclin-dependent kinases. Trends Biochem Sci 30, 630-641 (2005).
15. Dhillon, S. Palbociclib: first global approval. Drugs. 75, 543-551 (2015).
16. Kumar, S. K. et al. Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-Agent activity in patients with relapsed multiple myeloma. Blood. 125, 443-448 (2015).
17. Seto, T. et al. Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours. Cancer Chemoth Pharm 72, 619-627 (2013).
18. Inc, P. IBRANCE® (palbociclib): US prescribing information. http://www.accessdata.fda.gov (2015).
19. Bu, M., Yang, B. B. & Hu, L. Natural Endoperoxides as Drug Lead Compounds. Curr Med Chem 23, 383-405 (2016).
20. Su, J. et al. Qualitative and quantitative determination of the major coumarins in Zushima by high performance liquid chromatography with diode array detector and mass spectrometry. J Chromatogr A 1216, 2111-2117 (2009).
21. Su, J. et al. Flavonoids from Daphne giraldii Nitsche. Nat Prod Res 22, 1355-1358 (2008).
22. Su, J. et al. Two new bis-coumarin glycosides from Daphne giraldii NITSCHE. Chem. Pharm. Bull. 56, 589-591 (2008).
23. Xu, W. C., Shen, J. G. & Jiang, J. Q. Phytochemical and biological studies of the plants from the genus Daphne. Chem Biodivers. 8, 1215-1233 (2011).
24. Junko, M. et al. Components of Broussonetia pupvrijlera (L.) VENT. I.1) Structures of Two New Isoprenylated Flavonols and Two Chalcone Derivative. Chem. Pharm. Bull. 33, 3250-3256 (1985).
25. Deshpande, V. H., Parthasarathy, P. C. & Venkataraman, K. Four analogs of artocarpin and cycloartocarpin from Morus alba. Tetrahedron Lett. 9, 1715-1719 (1967).
26. Sun, Q. et al. Cytotoxic prenylated flavones from the stem and root bark of Daphne giraldii. Bioorg Med Chem Lett 26, 3968-3972 (2016).
27. Zhao, W. et al. Structure and cytotoxicity of diterpenoids from Isodon adenolomus. J Nat Prod 74, 1213-1220 (2011).
28. Hirsch, G. E. et al. gamma-Oryzanol Reduces Caveolin-1 and PCGEM1 Expression, Markers of Aggressiveness in Prostate Cancer Cell Lines. Prostate. 75, 783-797 (2015).
29. Jiang, Y. et al. Benzo(a)pyrene-induced mitochondrial dysfunction and cell death in p53-null Hep3B cells. Mutat Res. 726, 75-83 (2011).
30. Pang, Y., Qin, G., Wu, L., Wang, X. & Chen, T. Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells. Exp Cell Res 347, 251-260 (2016).
31. Schwartz, G. K. & Shah, M. A. Targeting the cell cycle: A new approach to cancer therapy. J Clin Oncol 23, 9408-9421 (2005).
32. O'Brien, M. A., Moravec, R. A. & Riss, T. L. Poly (ADP-ribose) polymerase cleavage monitored in situ in apoptotic cells. BioTechniques. 30, 886-891 (2001).
33. Huang, H. L. et al. MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer. Sci Rep 6, 31664 (2016).
34. Roovers, K. & Assoian, R. K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. BioEssays. 22, 818-826 (2000).
35. Zhang, X. Y. et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep 5, 12579 (2015).
36. Waskiewicz, A. J. & Cooper, J. A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr opin Cell Biol 7, 798-805 (1995).
37. Weng, M. S., Ho, Y. S. & Lin, J. K. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-Activated protein kinase. Biochem Pharmacol. 69, 1815-1827 (2005).
38. Zarubin, T. & Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11-18 (2005).
39. Nebreda, A. R. & Porras, A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci 25, 257-260 (2000).
40. Lin, A. & Dibling, B. The true face of JNK activation in apoptosis. Aging cell. 1, 112-116 (2002).
41. Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell. 103, 239-252 (2000).
42. Lenczowski, J. M. et al. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 17, 170-181 (1997).
43. Liu, J. & Lin, A. Role of JNK activation in apoptosis: A double-edged sword. Cell Res. 15, 36-42 (2005).
44. Gao, S. et al. Growth inhibitory effect of paratocarpin E, a prenylated chalcone isolated from Euphorbia humifusa Wild., by induction of autophagy and apoptosis in human breast cancer cells. Bioorg Chem. 69, 121-128 (2016).
45. Botta, B., Vitali, A., Menendez, P., Misiti, D. & Delle Monache, G. Prenylated flavonoids: pharmacology and biotechnology. Curr Med Chem 12, 717-739 (2005).
46. Minassi, A., Giana, A., Ech-Chahad, A. & Appendino, G. A regiodivergent synthesis of ring a C-prenylflavones. Org Lett. 10, 2267-2270 (2008).
47. Yang, D. S. et al. Cytotoxic prenylated bibenzyls and flavonoids from Macaranga kurzii. Fitoterapia. 99, 261-266 (2014).
48. Cho, M. H. et al. Magnetic Tandem Apoptosis for Overcoming Multidrug-Resistant Cancer. Nano Lett. 16, 7455-7460 (2016).
49. Kim, K. N. et al. Acanthoic acid induces cell apoptosis through activation of the p38 MAPK pathway in HL-60 human promyelocytic leukaemia. Food Chem. 135, 2112-2117 (2012).
50. Chao, J. I. & Yang, J. L. Opposite roles of ERK and p38 mitogen-Activated protein kinases in cadmium-induced genotoxicity and mitotic arrest. Chem Res Toxicol 14, 1193-1202 (2001).
51. Liao, G. et al. Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy. Sci Rep 6, 34564 (2016).
52. Ke, J. Y. et al. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways. Tumor Biol. 37, 14863-14872 (2016).